News
Metsera’s obesity drug candidate targeting the amylin hormone showed marked efficacy in an early trial, the company said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback